João L. Carapinha

Assessment of Glofitamab With Gemcitabine in DLBCL Reveals No Additional Benefit
Key Decisions on Health Technology Assessment at ACP124: Implications for Rar...
Unlocking Self-Care South Africa: Strategies and Challenges in Healthcare Reform
Strengthening the U.S. Pharmaceutical Supply Chain: Establishing a Strategic ...
Most Expensive Drugs 2025: Trends and Implications in US Pharma Pricing
Urgent Care Effectiveness: Exploring Canadian Centre Models and Health System...